<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="author at: Integrated Research Facility, National Institute of Allergy and" exact="Infectious" post="Diseases, National Institutes of Health, 8200 Research Plaza, Fort"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
 <result pre="centre remains active. Abstract A number of small-molecule drugs inhibit" exact="viral" post="replication by binding directly to virion structural proteins or"/>
 <result pre="virion structural proteins or to the active site of a" exact="viral" post="enzyme, or are chemically modified by a viral enzyme"/>
 <result pre="of a viral enzyme, or are chemically modified by a" exact="viral" post="enzyme before inhibiting a downstream process. Similarly, antibodies used"/>
 <result pre="a downstream process. Similarly, antibodies used to prevent or treat" exact="viral" post="infections attach to epitopes on virions or on viral"/>
 <result pre="downstream process. Similarly, antibodies used to prevent or treat viral" exact="infections" post="attach to epitopes on virions or on viral proteins"/>
 <result pre="treat viral infections attach to epitopes on virions or on" exact="viral" post="proteins expressed on the surface of infected cells. Such"/>
 <result pre="therefore be thought of as probes for the detection of" exact="viral" post="infections, suggesting that they might be used as radiolabeled"/>
 <result pre="might be used as radiolabeled tracers to visualize sites of" exact="viral" post="replication by single-photon emission computed tomography (SPECT) or positron"/>
 <result pre="current example of this approach is the PET imaging of" exact="herpes" post="simplex virus infections, in which the viral thymidine kinase"/>
 <result pre="PET imaging of herpes simplex virus infections, in which the" exact="viral" post="thymidine kinase phosphorylates radiolabeled thymidine analogues, trapping them within"/>
 <result pre="possible future applications might be the use of a radiolabeled" exact="hepatitis" post="C protease inhibitor to image infection in animals or"/>
 <result pre="use of a radiolabeled hepatitis C protease inhibitor to image" exact="infection" post="in animals or humans and provide a quantitative measure"/>
 <result pre="in animals or humans and provide a quantitative measure of" exact="viral" post="burden. This article reviews the basic features of radionuclide"/>
 <result pre="unsuitable pharmacokinetic profile or hepato- or nephrotoxicity. Keywords Antiviral therapy" exact="Infectious" post="disease imaging Single-photon emission computed tomography Positron emission tomography"/>
 <result pre="pharmacokinetic profile or hepato- or nephrotoxicity. Keywords Antiviral therapy Infectious" exact="disease" post="imaging Single-photon emission computed tomography Positron emission tomography Radiopharmaceuticals"/>
 <result pre="to image host responses to infection, rather than to visualize" exact="viral" post="replication. The only instance in which a pathogen-specific tracer"/>
 <result pre="been the use of a radiolabeled thymidine analogue to image" exact="herpes" post="simplex virus (HSV) infections, based on phosphorylation of the"/>
 <result pre="(HSV) infections, based on phosphorylation of the probe by the" exact="viral" post="thymidine kinase (TK), which traps it within infected cells"/>
 <result pre="peptide that is too large or too highly charged to" exact="diffuse" post="through the cell membrane can be used to target"/>
 <result pre="probe may undergo phosphorylation by a cellular (e.g. hexokinase) or" exact="viral" post="(HSV-TK) enzyme, so that it cannot diffuse out of"/>
 <result pre="(e.g. hexokinase) or viral (HSV-TK) enzyme, so that it cannot" exact="diffuse" post="out of the cell. (Figure by Fabian De Kok-Mercado)"/>
 <result pre="probe is [18F]-2′-fluoro-2′-deoxy-1-b- d-β-arabinofuranosyl-5-ethyluracil (18F-FEAU), which is phosphorylated by the" exact="viral" post="TK, but is not a substrate for the corresponding"/>
 <result pre="control mice. C shows additional uptake of probe in virus-infected" exact="tumor" post="metastases in inguinal and popliteal lymph nodes. From Brader"/>
 <result pre="antiviral drugs or antibodies as probes. In the case of" exact="hepatitis" post="C, for example, such tracers might include molecules that"/>
 <result pre="C, for example, such tracers might include molecules that block" exact="viral" post="replication by binding to specific virus-encoded molecules, such as"/>
 <result pre="targets for virus-specific imaging probes in the replication cycle of" exact="hepatitis" post="C virus. 1. Binding of a peptide inhibitor to"/>
 <result pre="of a peptide inhibitor to a fusion sequence in the" exact="viral" post="envelope glycoprotein. 2. Binding of an inhibitor to the"/>
 <result pre="Binding of an inhibitor to the active site of the" exact="viral" post="NS3 protease. 3. Binding of a non-nucleoside inhibitor to"/>
 <result pre="complex. 4. Binding of an antibody or aptamer to the" exact="viral" post="E1–E2 protein on the cell surface. (Figure by Fabian"/>
 <result pre="and PET have been used to detect host responses to" exact="viral infection" post="and examine how PET has been employed to track"/>
 <result pre="PET have been used to detect host responses to viral" exact="infection" post="and examine how PET has been employed to track"/>
 <result pre="conditions. Next, we identify a number of processes unique to" exact="viral" post="replication that might serve as targets for radiolabeled pathogen-specific"/>
 <result pre="beneficial effect within a region of interest (a locus of" exact="viral" post="infection), while having a minimal impact on other tissues."/>
 <result pre="electical signal and converted to an image by a computer." exact="Gamma" post="rays originating outside the area of interest are blocked"/>
 <result pre="of response to treatment, and are especially useful for monitoring" exact="cancer" post="therapy. 2.3 Considerations in the design of SPECT and"/>
 <result pre="healthy macaque, showing uptake of the 111In-labeled anti-CD4 antibody DTPA-OKT4A/hIgG4." exact="Lymphoid" post="tissues are identified. From Di Mascio et al. (2009a),"/>
 <result pre="the therapeutic molecule occupies a target site, and only a" exact="limited" post="number of sites are available for binding. Examples include"/>
 <result pre="to form 18F-DG (FDG), without changing its metabolic activity. Because" exact="malignant" post="cells tend to have a high rate of glucose"/>
 <result pre="site, the success of imaging a non-saturable target is not" exact="limited" post="by the number of targets within the region of"/>
 <result pre="SPECT isotopes, on the other hand, emit photons in the" exact="lower" post="energy range of 60–400 kEV, which are more likely"/>
 <result pre="appropriate for labeling large molecules with slow pharmacokinetics, due to" exact="short" post="half-life Nucleophilic or electrophilic substitution 64Cu 12.7 h Useful"/>
 <result pre="substitution 64Cu 12.7 h Useful for probes with slow pharmacokinetics" exact="Limited" post="commercial availability and expensive Metal chelation 76Br 16.2 h"/>
 <result pre="expensive Metal chelation 76Br 16.2 h Direct labeling of probe" exact="Limited" post="commercial availability and expensive Halide addition or substitution 89Zr"/>
 <result pre="a useful image. The need for chemical stability and a" exact="short" post="half-life can both potentially be met by performing PET"/>
 <result pre="repeatedly, at intervals of a few hours. However, the isotope's" exact="short" post="half-life means that its use is only practical if"/>
 <result pre="first approach includes the introduction of the radionuclide into the" exact="primary" post="synthetic reaction and its direct exchange for its stable"/>
 <result pre="the primary synthetic reaction and its direct exchange for its" exact="stable" post="counterpart. The second includes three different techniques: chemical modification"/>
 <result pre="attachment of the radionuclide to the probe should be sufficiently" exact="stable" post="to ensure that it remains in place while it"/>
 <result pre="Tracer pharmacokinetics Successful in vivo imaging depends upon the proper" exact="systemic" post="distribution, cellular uptake and elimination of a tracer following"/>
 <result pre="a pharmacokinetic pattern would provide optimal contrast between sites of" exact="viral" post="replication and normal tissues.) Because clearance takes time, the"/>
 <result pre="the pico- to nanomolar range. 3 Imaging host responses to" exact="viral infection" post="Radionuclide imaging has been used to study viral diseases"/>
 <result pre="pico- to nanomolar range. 3 Imaging host responses to viral" exact="infection" post="Radionuclide imaging has been used to study viral diseases"/>
 <result pre="to viral infection Radionuclide imaging has been used to study" exact="viral" post="diseases for more than three decades, by employing indirect"/>
 <result pre="the 1970s, it was found that cytomegalovirus pneumonitis and other" exact="infections" post="in immunodeficient patients could be detected by administering a"/>
 <result pre="al., 1986). As a result of increased perfusion and enhanced" exact="vascular" post="permeability, the radionuclide accumulated at sites of infection. Other"/>
 <result pre="cells with high levels of glucose metabolism, which occur in" exact="infectious" post="and inflammatory processes (Love et al., 2005, Mackie, 2004)."/>
 <result pre="with HIV-related dementia, as shown by a measurable reduction in" exact="cerebral" post="18F-FDG retention (Brunetti et al., 1989, Yarchoan et al.,"/>
 <result pre="Yarchoan et al., 1987). The same technique has shown that" exact="peripheral" post="lymph nodes have a greater glucose uptake in untreated"/>
 <result pre="on antiretroviral therapy, indicating that lymph nodes are sites of" exact="viral" post="replication (Brust et al., 2006). FDG-PET was used recently"/>
 <result pre="intense inflammatory response was present both in areas of dense" exact="pulmonary" post="consolidation as seen by CT scan and in regions"/>
 <result pre="probe, to determine the relative chronology and physical distribution of" exact="viral" post="replication and host inflammatory responses. 4 PET imaging of"/>
 <result pre="inhaled dose of radiolabeled zanamivir, another inhibitor of the influenza" exact="viral" post="neuraminidase, in human subjects (Bergstrom et al., 1999, Cass"/>
 <result pre="to detect and track the spread of virus in the" exact="respiratory" post="tract. 5 Proof of concept: recombinant viruses encoding imaging"/>
 <result pre="concept: recombinant viruses encoding imaging reporters The nascent field of" exact="cancer" post="&quot;virotherapy&quot; exploits the ability of viruses to replicate selectively"/>
 <result pre="&quot;virotherapy&quot; exploits the ability of viruses to replicate selectively in" exact="malignant" post="cells as a novel approach to killing tumors. To"/>
 <result pre="encode a reporter for radionuclide imaging. Examples include: •a recombinant" exact="vaccinia" post="virus encoding the human norepinephrine transporter, which enables PET"/>
 <result pre="al., 2009b); Fig. 8 PET image of a mouse with" exact="bilateral" post="tumors, one of which has been inoculated with a"/>
 <result pre="tumors, one of which has been inoculated with a recombinant" exact="vaccinia" post="virus encoding the human norepinephrine transporter. The probe, 124I-MIBG,"/>
 <result pre="tumor. From Chen et al. (2009b), with permission. •a recombinant" exact="vaccinia" post="virus encoding the type-2 somatostatin receptor, which binds the"/>
 <result pre="be imaged by gamma scanning (McCart et al., 2004); •recombinant" exact="measles" post="and vesicular stomatitis viruses encoding the thyroidal sodium iodide"/>
 <result pre="gamma scanning (McCart et al., 2004); •recombinant measles and vesicular" exact="stomatitis" post="viruses encoding the thyroidal sodium iodide symporter, which causes"/>
 <result pre="of introducing a gene encoding an imaging reporter into a" exact="viral" post="genome provides proof of concept for the notion of"/>
 <result pre="the introduction of an additional gene may interfere significantly with" exact="viral" post="replication. This problem was observed, for example, when a"/>
 <result pre="al., 2007). The ideal imaging approach for the study of" exact="viral" post="infections in laboratory animals should therefore make use of"/>
 <result pre="2007). The ideal imaging approach for the study of viral" exact="infections" post="in laboratory animals should therefore make use of unmodified"/>
 <result pre="is based on their ability to undergo phosphorylation by the" exact="viral" post="thymidine kinase (TK), but not by corresponding host enzymes."/>
 <result pre="is eliminated by the kidneys. In HSV-infected cells, however, the" exact="viral" post="TK converts acyclovir to its monophosphate, which is then"/>
 <result pre="for the host enzyme, it is preferentially incorporated into replicating" exact="viral" post="genomes, causing chain termination (Elion, 1983). The selective retention"/>
 <result pre="increasing the target-to-background ratio. Until recently, efforts to image HSV" exact="infections" post="have focused on detecting and monitoring viral encephalitis in"/>
 <result pre="to image HSV infections have focused on detecting and monitoring" exact="viral encephalitis" post="in laboratory animals. Beginning in the early 1980s, investigators"/>
 <result pre="image HSV infections have focused on detecting and monitoring viral" exact="encephalitis" post="in laboratory animals. Beginning in the early 1980s, investigators"/>
 <result pre="barrier normally restricts the entry of deoxythymidine analogues into the" exact="central nervous system," post="the increased permeability associated with viral infection permitted the"/>
 <result pre="into the central nervous system, the increased permeability associated with" exact="viral infection" post="permitted the entry of a sufficient amount of probe"/>
 <result pre="the central nervous system, the increased permeability associated with viral" exact="infection" post="permitted the entry of a sufficient amount of probe"/>
 <result pre="Saito et al., 1984, Cleator et al., 1988). Foci of" exact="encephalitis" post="were identified either by killing animals and performing autoradiography"/>
 <result pre="al., 2000). In general, this experience has shown that the" exact="limited" post="transport of probe across the blood–brain barrier significantly restricts"/>
 <result pre="to those discouraging results, success in PET imaging of HSV" exact="infections" post="has recently been reported in a different area of"/>
 <result pre="different area of research: the use of viruses for experimental" exact="cancer" post="therapy. Herpesviruses are one of a number of agents"/>
 <result pre="are being explored for their capacity to infect and kill" exact="tumor" post="cells. The fact that they naturally encode a TK"/>
 <result pre="in laboratory animals can readily be monitored by radionuclide imaging." exact="Viral" post="replication in tumors has been virualized using several different"/>
 <result pre="2007). This work thus represents the first success in imaging" exact="viral" post="replication in a living animal by targeting a naturally"/>
 <result pre="to phosphorylate nucleosides. Because UL97 recognizes acyclovir to only a" exact="limited" post="extent, the drug cannot be used to treat CMV"/>
 <result pre="(FHPG), has been evaluated as a probe to image CMV" exact="infections" post="(Alauddin et al., 1996, de Vries et al., 2000)."/>
 <result pre="PET scanning using 18F-FHPG was shown to correctly identify CMV" exact="encephalitis" post="in rats, as confirmed by autoradiography, but the utility"/>
 <result pre="autoradiography, but the utility of the approach was once again" exact="limited" post="by the restricted entry of the probe across the"/>
 <result pre="reporter for radionuclide imaging. For example, recombinant HIV and simian" exact="immunodeficiency" post="(SIV) viruses encoding the HSV-1 TK has been constructed"/>
 <result pre="these recombinant agents could also be employed to study retroviral" exact="infections" post="in animals by SPECT or PET. In addition to"/>
 <result pre="therapeutic approach, HSV itself is now being harnessed to kill" exact="malignant" post="cells, and its distribution and replication are being monitored"/>
 <result pre="lymphoma, with the anti-cancer drug bortezomib triggers expression of the" exact="viral" post="TK, making it possible not only for the tumors"/>
 <result pre="poxviruses also encode their own TK. Because it is a" exact="type II" post="enzyme, however, with a substrate specificity similar to that"/>
 <result pre="identified some thymidine analogues that inhibit the replication of wild-type" exact="vaccinia" post="virus significantly better than a virus lacking a TK"/>
 <result pre="have little value for imaging. In an interesting parallel to" exact="viral" post="infections, many genera of bacteria encode a type I"/>
 <result pre="parallel to viral infections, many genera of bacteria encode a" exact="type I" post="TK, making them susceptible to antiherpesviral drugs. Imaging researchers"/>
 <result pre="study employed 124I-FIAU as a PET probe to detect staphylococcal" exact="infections" post="following joint surgery (Fig. 9 ) (Bettegowda et al.,"/>
 <result pre="2007). The same approach has been used to image Mycobacterium" exact="tuberculosis" post="in animals, even though the organism lacks its own"/>
 <result pre="researchers were able to use 125I-FIAU to visualize sites of" exact="infection" post="by SPECT (Davis et al., 2009). Fig. 9 PET/CT"/>
 <result pre="SPECT (Davis et al., 2009). Fig. 9 PET/CT image of" exact="septic arthritis" post="in the right knee of a patient, using the"/>
 <result pre="(Davis et al., 2009). Fig. 9 PET/CT image of septic" exact="arthritis" post="in the right knee of a patient, using the"/>
 <result pre="arthritis in the right knee of a patient, using the" exact="bacterial" post="TK as the reporter and 124I-FIAU as the probe."/>
 <result pre="with permission. 7 Beyond TK: other imaging targets in the" exact="viral" post="replication cycle The only naturally occurring virus-encoded molecule that"/>
 <result pre="imaging. In the following sections, we review basic steps in" exact="viral" post="replication that could be exploited for PET or SPECT."/>
 <result pre="SPECT. A number of these steps are identified in the" exact="hepatitis" post="C virus replication cycle (Fig. 3). 7.1 Binding, membrane"/>
 <result pre="the entry process. 7.2 Transcription and genome duplication Once the" exact="viral" post="genome has been delivered into the cytoplasm, gene transcription"/>
 <result pre="design of analogues that are accepted as substrates by the" exact="viral" post="RNA or DNA polymerase, resulting either in chain termination"/>
 <result pre="impairing their subsequent function. Because most drugs that inhibit the" exact="viral" post="polymerase are converted to their monophosphate by a cellular"/>
 <result pre="for HIV therapy, and is now being used to target" exact="hepatitis" post="C and other viruses, is to identify non-nucleoside molecules"/>
 <result pre="that bind to a locus on the surface of the" exact="viral" post="polymerase, rather than to its active site, inducing a"/>
 <result pre="have potential as imaging probes. While transcription is taking place," exact="viral" post="mRNA must be modified to ensure its efficient translation,"/>
 <result pre="as virus-specific probes, because they do not bind to a" exact="viral" post="target. In contrast, compounds that specifically block a virus-encoded"/>
 <result pre="good tracers for radionuclide imaging (Dong et al., 2008). 7.3" exact="Protein" post="cleavage by a virus-encoded enzyme Translation of viral mRNA"/>
 <result pre="2008). 7.3 Protein cleavage by a virus-encoded enzyme Translation of" exact="viral" post="mRNA by the host cell protein-synthetic machinery is often"/>
 <result pre="the host cell, the active sites of a number of" exact="viral" post="proteases have proven to be rewarding targets for antiviral"/>
 <result pre="surface of the cell membrane, where assembly and release of" exact="viral" post="particles takes place. Efforts to develop specific inhibitors of"/>
 <result pre="tracer molecules. 7.5 Targets on the surface of virus-infected cells" exact="Viral" post="envelope proteins accumulate on the cell surface during the"/>
 <result pre="probes such as radiolabeled antibodies. Interestingly, certain tumors induced by" exact="viral infection," post="such as EBV-associated lymphomas, hepatocellular carcinoma in patients with"/>
 <result pre="certain tumors induced by viral infection, such as EBV-associated lymphomas," exact="hepatocellular carcinoma" post="in patients with hepatitis B and C and cervical"/>
 <result pre="tumors induced by viral infection, such as EBV-associated lymphomas, hepatocellular" exact="carcinoma" post="in patients with hepatitis B and C and cervical"/>
 <result pre="infection, such as EBV-associated lymphomas, hepatocellular carcinoma in patients with" exact="hepatitis" post="B and C and cervical carcinomas induced by papillomaviruses,"/>
 <result pre="B and C and cervical carcinomas induced by papillomaviruses, express" exact="viral" post="antigens, making them vulnerable to destruction by antibodies tagged"/>
 <result pre="to eradicate HIV in individuals with low levels of residual" exact="infection" post="(Casadevall et al., 2007). A similar strategy, using antibodies"/>
 <result pre="Could drugs other than anti-HSV medications be used to visualize" exact="viral" post="infections by SPECT or PET? Most licensed antivirals are"/>
 <result pre="drugs other than anti-HSV medications be used to visualize viral" exact="infections" post="by SPECT or PET? Most licensed antivirals are nucleoside"/>
 <result pre="of the virion surface GP2 molecules, both compounds interfere with" exact="viral" post="entry, but the specific mechanism is not known. 8.2"/>
 <result pre="protein cleavage during the coronavirus replication cycle has made the" exact="viral" post="papain-like (Plpro) and chymotrypsin-like (3Clpro) proteases major targets for"/>
 <result pre="the SARS coronavirus, and might also be used to image" exact="infections" post="(Ghosh et al., 2008, Ratia et al., 2008). 8.3"/>
 <result pre="causing cellular toxicity, suggesting that they are specific for the" exact="viral" post="target (Lescar et al., 2008). The small-molecule BILN 2061,"/>
 <result pre="BILN 2061, which binds to the active site of the" exact="hepatitis" post="C virus NS3, was effective in reducing viral load"/>
 <result pre="of the hepatitis C virus NS3, was effective in reducing" exact="viral" post="load in patients (Lamarre et al., 2003). Although its"/>
 <result pre="2009). Others are now under evaluation for the treatment of" exact="hepatitis" post="C. •The C-terminal portion of the flavivirus NS3 molecules"/>
 <result pre="which is essential for replication. Inhibitors have been identified for" exact="hepatitis" post="C and other flaviviruses (Leyssen et al., 2008, Lescar"/>
 <result pre="flaviviruses (Leyssen et al., 2008, Lescar et al., 2008). •The" exact="hepatitis" post="C virion surface glycoproteins E1 and E2 are expressed"/>
 <result pre="amantadine or rimantadine could be used to localize an influenza" exact="virus infection" post="and track it's spread, both in laboratory animals and"/>
 <result pre="or rimantadine could be used to localize an influenza virus" exact="infection" post="and track it's spread, both in laboratory animals and"/>
 <result pre="provide useful information on drug distribution and the extent of" exact="viral infection." post="8.6 Paramyxoviruses •Two small-molecule compounds, VP-14637 and JNJ-2408068, block"/>
 <result pre="•Two small-molecule compounds, VP-14637 and JNJ-2408068, block the entry of" exact="respiratory" post="syncytial virus (RSV) into cells at low nanomolar concentrations"/>
 <result pre="the target of the human mab palivizumab, used to prevent" exact="infection" post="in high-risk infants (Georgescu and Chemaly, 2009). A new"/>
 <result pre="antibody, motavizumab, with a greater virus-specific binding affinity and a" exact="lower" post="degree of nonspecific binding to host tissues, has recently"/>
 <result pre="and Nipah, are the targets of peptide mimics, which block" exact="infection" post="in vitro at low nanomolar concentrations (Porotto et al.,"/>
 <result pre="among the four capsid proteins, so as to release the" exact="viral" post="genome into the cytoplasm. A number of compounds have"/>
 <result pre="1986). The highly specific interaction of such compounds with the" exact="viral" post="capsid suggests that they could be used to image"/>
 <result pre="enzyme's active site (De Palma et al., 2008). Because the" exact="viral" post="enzyme has no known human homologue, it should be"/>
 <result pre="enviroxime inhibits the replication of rhinoviruses and enteroviruses by blocking" exact="viral" post="RNA replication, apparently by directly inhibiting the action of"/>
 <result pre="the 3A protein. The compound protected mice against lethal Coxsackie" exact="myocarditis" post="and has shown activity in protecting humans against rhinoviruses"/>
 <result pre="for antiviral therapy. The small-molecule ST-246 interacts specifically with the" exact="vaccinia" post="virus F13L protein, which is involved in the addition"/>
 <result pre="cells, animals and humans, suggesting that it uniquely targets the" exact="viral" post="enzyme, and could therefore be used as a radiolabeled"/>
 <result pre="could therefore be used as a radiolabeled probe to image" exact="poxvirus infections." post="8.9 Retroviruses •The HIV fusion inhibitor, T-20, is a"/>
 <result pre="polypeptide that binds to the hydrophobic fusion region of the" exact="viral" post="GP41, preventing it from undergoing the conformational change required"/>
 <result pre="of such compounds are now licensed for the treatment of" exact="HIV infection" post="(Sluis-Cremer and Tachedjian, 2008). Because no equivalent of the"/>
 <result pre="such compounds are now licensed for the treatment of HIV" exact="infection" post="(Sluis-Cremer and Tachedjian, 2008). Because no equivalent of the"/>
 <result pre="effective antiviral drugs was first proven for the treatment of" exact="HIV infection," post="and a number of different compounds are now approved"/>
 <result pre="that it may also be preferentially retained at sites of" exact="infection" post="in vivo. Additional studies would include testing the specificity"/>
 <result pre="if radiolabeled drug has preferentially been retained at sites of" exact="viral infection." post="To check for specificity, various amounts of unlabeled (&quot;cold&quot;)"/>
 <result pre="of interest are removed, samples are collected for determination of" exact="viral" post="titer by plaque titration and of probe concentration by"/>
 <result pre="sections are prepared for immunohistologic study. If sites of maximum" exact="viral" post="replication also show the highest levels of radioactivity, and"/>
 <result pre="replication also show the highest levels of radioactivity, and much" exact="lower" post="signals are detected in uninfected tissues, this would suggest"/>
 <result pre="to design initial studies in an appropriate animal model of" exact="viral infection." post="In addition to offering a second application for certain"/>
 <result pre="a second application for certain licensed antivirals that directly target" exact="viral" post="replication, radionuclide imaging may also provide a use for"/>
 <result pre="the case of deoxyglucose, which failed in trials as a" exact="cancer" post="drug, but is now the most widely used tracer"/>
 <result pre="probes. References References AlauddinM.M.ContiP.S.MazzaS.M.HamzehF.M.LeverJ.R.9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of" exact="viral infection" post="and gene therapy using PETNucl. Med. Biol.2319967877928940722 BeigelJ.BrayM.Current and"/>
 <result pre="References References AlauddinM.M.ContiP.S.MazzaS.M.HamzehF.M.LeverJ.R.9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral" exact="infection" post="and gene therapy using PETNucl. Med. Biol.2319967877928940722 BeigelJ.BrayM.Current and"/>
 <result pre="therapy of severe seasonal and avian influenzaAntiviral Res.7820089110218328578 BellaniG.GuerraL.PesentiA.MessaC.Imaging of" exact="lung inflammation" post="during severe influenza A: H1N1Intensive Care Med.36201071771820098980 BellaniG.MessaC.GuerraL.SpagnolliE.FotiG.PatronitiN.FumagalliR.MuschG.FazioF.PesentiA.Lungs of"/>
 <result pre="severe influenza A: H1N1Intensive Care Med.36201071771820098980 BellaniG.MessaC.GuerraL.SpagnolliE.FotiG.PatronitiN.FumagalliR.MuschG.FazioF.PesentiA.Lungs of patients with" exact="acute respiratory distress syndrome" post="show diffuse inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose"/>
 <result pre="influenza A: H1N1Intensive Care Med.36201071771820098980 BellaniG.MessaC.GuerraL.SpagnolliE.FotiG.PatronitiN.FumagalliR.MuschG.FazioF.PesentiA.Lungs of patients with acute" exact="respiratory" post="distress syndrome show diffuse inflammation in normally aerated regions:"/>
 <result pre="H1N1Intensive Care Med.36201071771820098980 BellaniG.MessaC.GuerraL.SpagnolliE.FotiG.PatronitiN.FumagalliR.MuschG.FazioF.PesentiA.Lungs of patients with acute respiratory distress" exact="syndrome" post="show diffuse inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose"/>
 <result pre="Med.36201071771820098980 BellaniG.MessaC.GuerraL.SpagnolliE.FotiG.PatronitiN.FumagalliR.MuschG.FazioF.PesentiA.Lungs of patients with acute respiratory distress syndrome show" exact="diffuse" post="inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose PET/CT studyCrit."/>
 <result pre="[18F]-fluoro-2-deoxy-D-glucose PET/CT studyCrit. Care Med.3720092216222219487931 BennettJ.J.TjuvajevJ.JohnsonP.DoubrovinM.AkhurstT.MalholtraS.HackmanT.BalatoniJ.FinnR.LarsonS.M.FederoffH.BlasbergR.FongY.Positron emission tomography imaging for" exact="herpes" post="virus infection: implications for oncolytic viral treatments of cancerNat."/>
 <result pre="emission tomography imaging for herpes virus infection: implications for oncolytic" exact="viral" post="treatments of cancerNat. Med.7200185986311433353 BergstromM.CassL.M.ValindS.WesterbergG.LundbergE.L.GrayS.ByeA.LangstromB.Deposition and disposition of [11C]zanamivir"/>
 <result pre="intranasal spray. Evaluation with positron emission tomographyClin. Pharmacokinet.36Suppl. 11999333910429838 BettegowdaC.FossC.A.CheongI.WangY.DiazL.AgrawalN.FoxJ.DickJ.DangL.H.ZhouS.KinzlerK.W.VogelsteinB.PomperM.G.Imaging" exact="bacterial infections" post="with radiolabeled 1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl)-5-iodouracilProc. Natl. Acad. Sci. USA10220051145115015653773 BolkenT.C.LaquerreS.ZhangY.BaileyT.R.PevearD.C.KicknerS.S.SperzelL.E.JonesK.F.WarrenT.K.Amanda LundS.Kirkwood-WattsD.L.KingD.S.ShurtleffA.C.GuttieriM.C.DengY.BleamM.HrubyD.E.Identification"/>
 <result pre="spray. Evaluation with positron emission tomographyClin. Pharmacokinet.36Suppl. 11999333910429838 BettegowdaC.FossC.A.CheongI.WangY.DiazL.AgrawalN.FoxJ.DickJ.DangL.H.ZhouS.KinzlerK.W.VogelsteinB.PomperM.G.Imaging bacterial" exact="infections" post="with radiolabeled 1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl)-5-iodouracilProc. Natl. Acad. Sci. USA10220051145115015653773 BolkenT.C.LaquerreS.ZhangY.BaileyT.R.PevearD.C.KicknerS.S.SperzelL.E.JonesK.F.WarrenT.K.Amanda LundS.Kirkwood-WattsD.L.KingD.S.ShurtleffA.C.GuttieriM.C.DengY.BleamM.HrubyD.E.Identification"/>
 <result pre="arenavirusesAntiviral Res.692006869716343651 BraderP.KellyK.GangS.ShahJ.P.WongR.J.HricakH.BlasbergR.G.FongY.GilZ.Imaging of lymph node micrometastases using an oncolytic" exact="herpes" post="virus and [F]FEAU PETPLoS One42009e478919274083 BrunettiA.BergG.Di ChiroG.CohenR.M.YarchoanR.PizzoP.A.BroderS.EddyJ.FulhamM.J.FinnR.D.Reversal of brain"/>
 <result pre="One42009e478919274083 BrunettiA.BergG.Di ChiroG.CohenR.M.YarchoanR.PizzoP.A.BroderS.EddyJ.FulhamM.J.FinnR.D.Reversal of brain metabolic abnormalities following treatment of" exact="AIDS dementia complex" post="with 3′-azido-2′,3′-dideoxythymidine (AZT, zidovudine): a PET-FDG studyJ. Nucl. Med.3019895815902785582"/>
 <result pre="BrunettiA.BergG.Di ChiroG.CohenR.M.YarchoanR.PizzoP.A.BroderS.EddyJ.FulhamM.J.FinnR.D.Reversal of brain metabolic abnormalities following treatment of AIDS" exact="dementia" post="complex with 3′-azido-2′,3′-dideoxythymidine (AZT, zidovudine): a PET-FDG studyJ. Nucl."/>
 <result pre="BrustD.PolisM.DaveyR.HahnB.BacharachS.WhatleyM.FauciA.S.CarrasquilloJ.A.Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of" exact="disease" post="stage and therapy on pattern of nodal activationAIDS20200698599316603850 BuscombeJ.R.OyenW.J.GrantA.ClaessensR.A.van"/>
 <result pre="of nodal activationAIDS20200698599316603850 BuscombeJ.R.OyenW.J.GrantA.ClaessensR.A.van der MeerJ.CorstensF.H.EllP.J.MillerR.F.Indium-111-labeled polyclonal human immunoglobulin: identifying" exact="focal" post="infection in patients positive for human immunodeficiency virusJ. Nucl."/>
 <result pre="nodal activationAIDS20200698599316603850 BuscombeJ.R.OyenW.J.GrantA.ClaessensR.A.van der MeerJ.CorstensF.H.EllP.J.MillerR.F.Indium-111-labeled polyclonal human immunoglobulin: identifying focal" exact="infection" post="in patients positive for human immunodeficiency virusJ. Nucl. Med.341993162116258410271"/>
 <result pre="human immunoglobulin: identifying focal infection in patients positive for human" exact="immunodeficiency" post="virusJ. Nucl. Med.341993162116258410271 BuursmaA.R.de VriesE.F.GarssenJ.KeglerD.van WaardeA.SchirmJ.HospersG.A.MulderN.H.VaalburgW.KleinH.C.[18F]FHPG positron emission tomography"/>
 <result pre="Med.341993162116258410271 BuursmaA.R.de VriesE.F.GarssenJ.KeglerD.van WaardeA.SchirmJ.HospersG.A.MulderN.H.VaalburgW.KleinH.C.[18F]FHPG positron emission tomography for detection of" exact="herpes" post="simplex virus (HSV) in experimental HSV encephalitisJ. Virol.7920057721772715919924 CagninA.KassiouM.MeikleS.R.BanatiR.B.Positron"/>
 <result pre="AIDSProc. Natl. Acad. Sci. USA931996981098158790413 ChapmanJ.AbbottE.AlberD.G.BaxterR.C.BithellS.K.HendersonE.A.CarterM.C.ChambersP.ChubbA.CockerillG.S.CollinsP.L.DowdellV.C.KeeganS.J.KelseyR.D.LockyerM.J.LuongoC.NajarroP.PicklesR.J.SimmondsM.TaylorD.TymsS.WilsonL.J.PowellK.L.RSV604, a novel inhibitor of" exact="respiratory" post="syncytial virus replicationAntimicrob. Agents Chemother.5120073346335317576833 ChenD.L.RosenbluthD.B.MintunM.A.SchusterD.P.FDG-PET imaging of pulmonary"/>
 <result pre="of respiratory syncytial virus replicationAntimicrob. Agents Chemother.5120073346335317576833 ChenD.L.RosenbluthD.B.MintunM.A.SchusterD.P.FDG-PET imaging of" exact="pulmonary" post="inflammation in healthy volunteers after airway instillation of endotoxinJ."/>
 <result pre="ChenD.L.SchusterD.P.Positron emission tomography with [18F]fluorodeoxyglucose to evaluate neutrophil kinetics during" exact="acute" post="lung injuryAm. J. Physiol. Lung Cell Mol. Physiol.2862004L834L84014660487 ChenF.HuY.LiD.ChenH.ZhangX.L.CS-SELEX"/>
 <result pre="Physiol.2862004L834L84014660487 ChenF.HuY.LiD.ChenH.ZhangX.L.CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for" exact="hepatitis" post="C virus envelope glycoprotein E2PLoS One42009e814219997645 ChenN.ZhangQ.YuY.A.StritzkerJ.BraderP.SchirbelA.SamnickS.SerganovaI.BlasbergR.FongY.SzalayA.A.A novel recombinant"/>
 <result pre="hepatitis C virus envelope glycoprotein E2PLoS One42009e814219997645 ChenN.ZhangQ.YuY.A.StritzkerJ.BraderP.SchirbelA.SamnickS.SerganovaI.BlasbergR.FongY.SzalayA.A.A novel recombinant" exact="vaccinia" post="virus expressing the human norepinephrine transporter retains oncolytic potential"/>
 <result pre="(I50) of an enzymatic reactionBiochem. Pharmacol.221973309931084202581 CleatorG.M.KlapperP.E.LewisA.G.SharmaH.L.LongsonM.Specific neuro-radiological diagnosis of" exact="herpes" post="encephalitis in an animal modelArch. Virol.10119881123415476 DadachovaE.PatelM.C.ToussiS.ApostolidisC.MorgensternA.BrechbielM.W.GornyM.K.Zolla-PaznerS.CasadevallA.GoldsteinH.Targeted killing of"/>
 <result pre="of an enzymatic reactionBiochem. Pharmacol.221973309931084202581 CleatorG.M.KlapperP.E.LewisA.G.SharmaH.L.LongsonM.Specific neuro-radiological diagnosis of herpes" exact="encephalitis" post="in an animal modelArch. Virol.10119881123415476 DadachovaE.PatelM.C.ToussiS.ApostolidisC.MorgensternA.BrechbielM.W.GornyM.K.Zolla-PaznerS.CasadevallA.GoldsteinH.Targeted killing of virally"/>
 <result pre="DadachovaE.PatelM.C.ToussiS.ApostolidisC.MorgensternA.BrechbielM.W.GornyM.K.Zolla-PaznerS.CasadevallA.GoldsteinH.Targeted killing of virally infected cells by radiolabeled antibodies to" exact="viral" post="proteinsPLoS Med.32006e42717090209 DavisS.L.BeN.A.LamichhaneG.NimmagaddaS.PomperM.G.BishaiW.R.JainS.K.Bacterial thymidine kinase as a non-invasive imaging"/>
 <result pre="DavisS.L.BeN.A.LamichhaneG.NimmagaddaS.PomperM.G.BishaiW.R.JainS.K.Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium" exact="tuberculosis" post="in live animalsPLoS One42009e629719606217 De PalmaA.M.VliegenI.De ClercqE.NeytsJ.Selective inhibitors of"/>
 <result pre="Rev.28200882388418381747 de VriesE.F.van WaardeA.HarmsenM.C.MulderN.H.VaalburgW.HospersG.A.[(11)C]FMAU and [(18)F]FHPG as PET tracers for" exact="herpes" post="simplex virus thymidine kinase enzyme activity and human cytomegalovirus"/>
 <result pre="De WinterF.VogelaersD.GemmelF.DierckxR.A.Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical" exact="infectious" post="diseasesEur. J. Clin. Microbiol. Infect. Dis.21200224725712072934 DeBlasiA.O’ReillyK.MotulskyH.J.Calculating receptor number"/>
 <result pre="compound as radioligand and competitorTrends Pharmacol. Sci.1019892272292773043 Deville-BonneD.El AmriC.MeyerP.ChenY.AgrofoglioL.A.JaninJ.Human and" exact="viral" post="nucleoside/nucleotide kinases involved in antiviral drug activation: structural and"/>
 <result pre="Di MascioM.PaikC.H.CarrasquilloJ.A.MaengJ.S.JangB.S.ShinI.S.SrinivasulaS.ByrumR.NeriaA.KoppW.CatalfamoM.NishimuraY.ReimannK.MartinM.LaneH.C.Noninvasive in vivo imaging of CD4 cells in simian-human" exact="immunodeficiency" post="virus (SHIV)-infected nonhuman primatesBlood114200932833719417212 Di MascioM.SrinivasulaS.BhattacharjeeA.ChengL.MartiniovaL.HerscovitchP.LertoraJ.KiesewetterD.Antiretroviral tissue kinetics: in"/>
 <result pre="imaging using positron emission tomographyAntimicrob. Agents Chemother.5320094086409519667288 DiazL.A.Jr.FossC.A.ThorntonK.NimmagaddaS.EndresC.J.UzunerO.SeylerT.M.UlrichS.D.ConwayJ.BettegowdaC.AgrawalN.CheongI.ZhangX.LadensonP.W.VogelsteinB.N.MontM.A.ZhouS.KinzlerK.W.VogelsteinB.PomperM.G.Imaging of musculoskeletal" exact="bacterial infections" post="by [124I]FIAU-PET/CTPLoS ONE22007e100717925855 DingliD.PengK.W.HarveyM.E.GreippP.R.O’ConnorM.K.CattaneoR.MorrisJ.C.RussellS.J.Image-guided radiovirotherapy for multiple myeloma using"/>
 <result pre="using positron emission tomographyAntimicrob. Agents Chemother.5320094086409519667288 DiazL.A.Jr.FossC.A.ThorntonK.NimmagaddaS.EndresC.J.UzunerO.SeylerT.M.UlrichS.D.ConwayJ.BettegowdaC.AgrawalN.CheongI.ZhangX.LadensonP.W.VogelsteinB.N.MontM.A.ZhouS.KinzlerK.W.VogelsteinB.PomperM.G.Imaging of musculoskeletal bacterial" exact="infections" post="by [124I]FIAU-PET/CTPLoS ONE22007e100717925855 DingliD.PengK.W.HarveyM.E.GreippP.R.O’ConnorM.K.CattaneoR.MorrisJ.C.RussellS.J.Image-guided radiovirotherapy for multiple myeloma using"/>
 <result pre="of musculoskeletal bacterial infections by [124I]FIAU-PET/CTPLoS ONE22007e100717925855 DingliD.PengK.W.HarveyM.E.GreippP.R.O’ConnorM.K.CattaneoR.MorrisJ.C.RussellS.J.Image-guided radiovirotherapy for" exact="multiple myeloma" post="using a recombinant measles virus expressing the thyroidal sodium"/>
 <result pre="musculoskeletal bacterial infections by [124I]FIAU-PET/CTPLoS ONE22007e100717925855 DingliD.PengK.W.HarveyM.E.GreippP.R.O’ConnorM.K.CattaneoR.MorrisJ.C.RussellS.J.Image-guided radiovirotherapy for multiple" exact="myeloma" post="using a recombinant measles virus expressing the thyroidal sodium"/>
 <result pre="[124I]FIAU-PET/CTPLoS ONE22007e100717925855 DingliD.PengK.W.HarveyM.E.GreippP.R.O’ConnorM.K.CattaneoR.MorrisJ.C.RussellS.J.Image-guided radiovirotherapy for multiple myeloma using a recombinant" exact="measles" post="virus expressing the thyroidal sodium iodide symporterBlood10320041641164614604966 DongH.ZhangB.ShiP.Y.Flavivirus methyltransferase:"/>
 <result pre="novel antiviral targetAntiviral Res.80200811018571739 DouglasJ.L.PanisM.L.HoE.LinK.Y.KrawczykS.H.GrantD.M.CaiR.SwaminathanS.ChenX.CihlarT.Small molecules VP-14637 and JNJ-2408068 inhibit" exact="respiratory" post="syncytial virus fusion by similar mechanismsAntimicrob. Agents Chemother.4920052460246615917547 DrummerH.E.MaerzA.PoumbouriosP.Cell"/>
 <result pre="by similar mechanismsAntimicrob. Agents Chemother.4920052460246615917547 DrummerH.E.MaerzA.PoumbouriosP.Cell surface expression of functional" exact="hepatitis" post="C virus E1 and E2 glycoproteinsFEBS Lett.546200338539012832074 DuraffourS.VigneS.VermeireK.GarcelA.VanstreelsE.DaelemansD.YangG.JordanR.HrubyD.E.CranceJ.M.GarinD.AndreiG.SnoeckR.Specific targeting"/>
 <result pre="radiopharmaceuticalsJ. Nucl. Med.20197935035743884 EckelmanW.C.RebaR.C.KelloffG.J.Targeted imaging: an important biomarker for understanding" exact="disease" post="progression in the era of personalized medicineDrug Discov. Today13200874875918617011"/>
 <result pre="binding techniques. Curr. Protoc. Neurosci. Chapter 1, Unit 1–4. FuD.X.TanhehcoY.C.ChenJ.FossC.A.FoxJ.J.LemasV.ChongJ.M.AmbinderR.F.PomperM.G.Virus-associated" exact="tumor" post="imaging by induction of viral gene expressionClin. Cancer Res.1320071453145817332288"/>
 <result pre="Chapter 1, Unit 1–4. FuD.X.TanhehcoY.C.ChenJ.FossC.A.FoxJ.J.LemasV.ChongJ.M.AmbinderR.F.PomperM.G.Virus-associated tumor imaging by induction of" exact="viral" post="gene expressionClin. Cancer Res.1320071453145817332288 GentryG.A.Viral thymidine kinases and their"/>
 <result pre="1–4. FuD.X.TanhehcoY.C.ChenJ.FossC.A.FoxJ.J.LemasV.ChongJ.M.AmbinderR.F.PomperM.G.Virus-associated tumor imaging by induction of viral gene expressionClin." exact="Cancer" post="Res.1320071453145817332288 GentryG.A.Viral thymidine kinases and their relativesPharmacol. Ther.5419923193551334563 GeorgescuG.ChemalyR.F.Palivizumab:"/>
 <result pre="Med. Chem. Lett.1820085684568818796354 GillM.J.SamuelJ.WiebeL.I.KnausE.E.TyrrellD.L.Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2′-deoxyuridine in" exact="herpes" post="simplex virus-infected cells in vitroAntimicrob. Agents Chemother.2519844764786732216 GoelA.CarlsonS.K.ClassicK.L.GreinerS.NaikS.PowerA.T.BellJ.C.RussellS.J.Radioiodide imaging"/>
 <result pre="cells in vitroAntimicrob. Agents Chemother.2519844764786732216 GoelA.CarlsonS.K.ClassicK.L.GreinerS.NaikS.PowerA.T.BellJ.C.RussellS.J.Radioiodide imaging and radiovirotherapy of" exact="multiple myeloma" post="using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the"/>
 <result pre="in vitroAntimicrob. Agents Chemother.2519844764786732216 GoelA.CarlsonS.K.ClassicK.L.GreinerS.NaikS.PowerA.T.BellJ.C.RussellS.J.Radioiodide imaging and radiovirotherapy of multiple" exact="myeloma" post="using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the"/>
 <result pre="and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular" exact="stomatitis" post="virus encoding the sodium iodide symporter geneBlood11020072342235017515401 GreenL.A.NguyenK.BerenjiB.IyerM.BauerE.BarrioJ.R.NamavariM.SatyamurthyN.GambhirS.S.A tracer"/>
 <result pre="symporter geneBlood11020072342235017515401 GreenL.A.NguyenK.BerenjiB.IyerM.BauerE.BarrioJ.R.NamavariM.SatyamurthyN.GambhirS.S.A tracer kinetic model for 18F-FHBG for quantitating" exact="herpes" post="simplex virus type 1 thymidine kinase reporter gene expression"/>
 <result pre="tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus" exact="type 1" post="thymidine kinase reporter gene expression in living animals using"/>
 <result pre="emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic" exact="herpes" post="simplex virus type 1 mutant vectors in vivoCancer Res.6120012983299511306477"/>
 <result pre="of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus" exact="type 1" post="mutant vectors in vivoCancer Res.6120012983299511306477 JagodaE.M.VaqueroJ.J.SeidelJ.GreenM.V.EckelmanW.C.Experiment assessment of mass"/>
 <result pre="saturation&quot; radioligand binding experimentsMethods Mol. Biol.7319973313429031220 KatzenellenbogenJ.A.CarlsonK.E.HeimanD.F.GoswamiR.Receptor-binding radiopharmaceuticals for imaging" exact="breast" post="tumors: estrogen-receptor interactions and selectivity of tissue uptake of"/>
 <result pre="uptake of halogenated estrogen analogsJ. Nucl. Med.2119805505586247466 KlapperP.E.CleatorG.M.BruceJ.M.LongsonM.Penetration of the" exact="blood-brain barrier" post="by the antiviral drug (E)-5-(2-iodovinyl)-2′-deoxyuridine in a rat model"/>
 <result pre="by the antiviral drug (E)-5-(2-iodovinyl)-2′-deoxyuridine in a rat model of" exact="herpes" post="encephalitisDrug Des. Deliv.3198857672855575 KonnoF.AraiT.ZhangM.R.HatoriA.YanamotoK.OgawaM.ItoG.OdawaraC.YamasakiT.KatoK.SuzukiK.Radiosyntheses of two positron emission tomography"/>
 <result pre="Chem. Lett.1820081260126318226899 KumarR.BasuS.TorigianD.AnandV.ZhuangH.AlaviA.Role of modern imaging techniques for diagnosis of" exact="infection" post="in the era of 18F-fluorodeoxyglucose positron emission tomographyClin. Microbiol."/>
 <result pre="KumarV.Radiolabeled white blood cells and direct targeting of micro-organisms for" exact="infection" post="imagingQ. J. Nucl. Med. Mol. Imaging49200532533816407816 KuruppuD.BrownellA.L.ZhuA.YuM.WangX.KuluY.FuchsB.C.KawasakiH.TanabeK.K.Positron emission tomography"/>
 <result pre="imagingQ. J. Nucl. Med. Mol. Imaging49200532533816407816 KuruppuD.BrownellA.L.ZhuA.YuM.WangX.KuluY.FuchsB.C.KawasakiH.TanabeK.K.Positron emission tomography of" exact="herpes" post="simplex virus 1 oncolysisCancer Res.6720073295330017409438 LamarreD.AndersonP.C.BaileyM.BeaulieuP.BolgerG.BonneauP.BosM.CameronD.R.CartierM.CordingleyM.G.FaucherA.M.GoudreauN.KawaiS.H.KukoljG.LagaceL.LaPlanteS.R.NarjesH.PoupartM.A.RancourtJ.SentjensR.E.St GeorgeR.SimoneauB.SteinmannG.ThibeaultD.TsantrizosY.S.WeldonS.M.YongC.L.Llinas-BrunetM.An NS3 protease"/>
 <result pre="NS3 protease inhibitor with antiviral effects in humans infected with" exact="hepatitis" post="C virusNature426200318618914578911 LangenP.EtzoldG.HintscheR.KowollikG.3′-Deoxy-3′-fluorothymidine, a new selective inhibitor of DNA-synthesisActa"/>
 <result pre="against flaviviruses: the case for the multifunctional NS3 protein from" exact="Dengue" post="virus as a targetAntiviral Res.8020089410118674567 LeyssenP.De ClercqE.NeytsJ.Molecular strategies to"/>
 <result pre="the therapy of syphilisBr. J. Vener. Dis.11925505721772477 LoveC.TomasM.B.TroncoG.G.PalestroC.J.FDG PET of" exact="infection" post="and inflammationRadiographics2520051357136816160116 MackieG.C.F-18 fluorodeoxyglucose positron emission tomographic imaging of"/>
 <result pre="positron emission tomographic imaging of cytomegalovirus pneumoniaClin. Nucl. Med.29200456957115311128 McCartJ.A.MehtaN.ScollardD.ReillyR.M.CarrasquilloJ.A.TangN.DengH.MillerM.XuH.LibuttiS.K.AlexanderH.R.BartlettD.L.Oncolytic" exact="vaccinia" post="virus expressing the human somatostatin receptor SSTR2: molecular imaging"/>
 <result pre="virus expressing the human somatostatin receptor SSTR2: molecular imaging after" exact="systemic" post="delivery using 111In-pentetreotideMol. Ther.10200455356115336655 McKinlayM.A.SteinbergB.A.Oral efficacy of WIN 51711"/>
 <result pre="and other imaging probesJ. Nucl. Med.49200863764818344433 NattermannJ.SchneidersA.M.LeifeldL.LanghansB.SchulzM.InchauspeG.MatzB.BrackmannH.H.HoughtonM.SauerbruchT.SpenglerU.Serum antibodies against the" exact="hepatitis" post="C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC)J."/>
 <result pre="cellular cytotoxicity (ADCC)J. Hepatol.42200549950415763336 PaeshuyseJ.LetellierC.FroeyenM.DutartreH.VranckenR.CanardB.De ClercqE.GueiffierA.TeuladeJ.C.HerdewijnP.PuerstingerG.KoenenF.KerkhofsP.BaraldiP.G.NeytsJ.A pyrazolotriazolopyrimidinamine inhibitor of bovine" exact="viral" post="diarrhea virus replication that targets the viral RNA-dependent RNA"/>
 <result pre="cytotoxicity (ADCC)J. Hepatol.42200549950415763336 PaeshuyseJ.LetellierC.FroeyenM.DutartreH.VranckenR.CanardB.De ClercqE.GueiffierA.TeuladeJ.C.HerdewijnP.PuerstingerG.KoenenF.KerkhofsP.BaraldiP.G.NeytsJ.A pyrazolotriazolopyrimidinamine inhibitor of bovine viral" exact="diarrhea" post="virus replication that targets the viral RNA-dependent RNA polymeraseAntiviral"/>
 <result pre="inhibitor of bovine viral diarrhea virus replication that targets the" exact="viral" post="RNA-dependent RNA polymeraseAntiviral Res.82200914114719428605 PatelS.GibsonR.In vivo site-directed radiotracers: a"/>
 <result pre="I. Biochemical uptake mechanism and its implication for clinical studiesJ." exact="Cancer" post="Res. Clin. Oncol.126200054955911043392 PhelpsM.E.Inaugural article: positron emission tomography provides"/>
 <result pre="the use of radiolabeled antiviral drugs in the diagnosis of" exact="herpes" post="simplex encephalitisBiochem. Pharmacol.321983245524616311219 PrichardM.N.Function of human cytomegalovirus UL97 kinase"/>
 <result pre="simplex encephalitisBiochem. Pharmacol.321983245524616311219 PrichardM.N.Function of human cytomegalovirus UL97 kinase in" exact="viral infection" post="and its inhibition by maribavirRev. Med. Virol.19200921522919434630 PrichardM.N.KeithK.A.JohnsonM.P.HardenE.A.McBrayerA.LuoM.QiuS.ChattopadhyayD.FanX.TorrenceP.F.KernE.R.Selective phosphorylation"/>
 <result pre="encephalitisBiochem. Pharmacol.321983245524616311219 PrichardM.N.Function of human cytomegalovirus UL97 kinase in viral" exact="infection" post="and its inhibition by maribavirRev. Med. Virol.19200921522919434630 PrichardM.N.KeithK.A.JohnsonM.P.HardenE.A.McBrayerA.LuoM.QiuS.ChattopadhyayD.FanX.TorrenceP.F.KernE.R.Selective phosphorylation"/>
 <result pre="by maribavirRev. Med. Virol.19200921522919434630 PrichardM.N.KeithK.A.JohnsonM.P.HardenE.A.McBrayerA.LuoM.QiuS.ChattopadhyayD.FanX.TorrenceP.F.KernE.R.Selective phosphorylation of antiviral drugs by" exact="vaccinia" post="virus thymidine kinaseAntimicrob. Agents Chemother.5120071795180317325220 PrichardM.N.WilliamsA.D.KeithK.A.HardenE.A.KernE.R.Distinct thymidine kinases encoded"/>
 <result pre="virus thymidine kinaseAntimicrob. Agents Chemother.5120071795180317325220 PrichardM.N.WilliamsA.D.KeithK.A.HardenE.A.KernE.R.Distinct thymidine kinases encoded by" exact="cowpox" post="virus and herpes simplex virus contribute significantly to the"/>
 <result pre="Agents Chemother.5120071795180317325220 PrichardM.N.WilliamsA.D.KeithK.A.HardenE.A.KernE.R.Distinct thymidine kinases encoded by cowpox virus and" exact="herpes" post="simplex virus contribute significantly to the differential antiviral activity"/>
 <result pre="FolmerS.C.DannerS.A.BakkerA.J.LangeJ.M.van SteenwijkR.P.AlbertsC.van KeulenP.H.van der SchootJ.B.Gallium-67 lung scintigraphy in patients with" exact="acquired" post="immune deficiency syndrome (AIDS)Eur. J. Respir. Dis.6819863133183015649 RudinM.RauschM.StoeckliM.Molecular imaging"/>
 <result pre="KeulenP.H.van der SchootJ.B.Gallium-67 lung scintigraphy in patients with acquired immune" exact="deficiency" post="syndrome (AIDS)Eur. J. Respir. Dis.6819863133183015649 RudinM.RauschM.StoeckliM.Molecular imaging in drug"/>
 <result pre="der SchootJ.B.Gallium-67 lung scintigraphy in patients with acquired immune deficiency" exact="syndrome" post="(AIDS)Eur. J. Respir. Dis.6819863133183015649 RudinM.RauschM.StoeckliM.Molecular imaging in drug discovery"/>
 <result pre="and limitations of nonnuclear methodsMol. Imaging Biol.7200551315912270 SaitoY.RubensteinR.PriceR.W.FoxJ.J.WatanabeK.A.Diagnostic imaging of" exact="herpes" post="simplex virus encephalitis using a radiolabeled antiviral drug: autoradiographic"/>
 <result pre="nonnuclear methodsMol. Imaging Biol.7200551315912270 SaitoY.RubensteinR.PriceR.W.FoxJ.J.WatanabeK.A.Diagnostic imaging of herpes simplex virus" exact="encephalitis" post="using a radiolabeled antiviral drug: autoradiographic assessment in an"/>
 <result pre="in clinical studiesNucl. Med. Biol.34200779180717921031 ShieldsA.F.Positron emission tomography measurement of" exact="tumor" post="metabolism and growth: its expanding role in oncologyMol. Imaging"/>
 <result pre="USA1012004179701797515611477 WoodwardG.E.HudsonM.T.The effect of 2-desoxy-D-glucose on glycolysis and respiration of" exact="tumor" post="and normal tissuesCancer Res.14195459960513199805 WuH.PfarrD.S.JohnsonS.BrewahY.A.WoodsR.M.PatelN.K.WhiteW.I.YoungJ.F.KienerP.A.Development of motavizumab, an ultra-potent"/>
 <result pre="WuH.PfarrD.S.JohnsonS.BrewahY.A.WoodsR.M.PatelN.K.WhiteW.I.YoungJ.F.KienerP.A.Development of motavizumab, an ultra-potent antibody for the prevention of" exact="respiratory" post="syncytial virus infection in the upper and lower respiratory"/>
 <result pre="motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial" exact="virus infection" post="in the upper and lower respiratory tractJ. Mol. Biol.368200765266517362988"/>
 <result pre="an ultra-potent antibody for the prevention of respiratory syncytial virus" exact="infection" post="in the upper and lower respiratory tractJ. Mol. Biol.368200765266517362988"/>
 <result pre="for the prevention of respiratory syncytial virus infection in the" exact="upper" post="and lower respiratory tractJ. Mol. Biol.368200765266517362988 YangG.PevearD.C.DaviesM.H.CollettM.S.BaileyT.RippenS.BaroneL.BurnsC.RhodesG.TohanS.HugginsJ.W.BakerR.O.BullerR.L.TouchetteE.WallerK.SchriewerJ.NeytsJ.DeClercqE.JonesK.HrubyD.JordanR.An orally bioavailable"/>
 <result pre="prevention of respiratory syncytial virus infection in the upper and" exact="lower" post="respiratory tractJ. Mol. Biol.368200765266517362988 YangG.PevearD.C.DaviesM.H.CollettM.S.BaileyT.RippenS.BaroneL.BurnsC.RhodesG.TohanS.HugginsJ.W.BakerR.O.BullerR.L.TouchetteE.WallerK.SchriewerJ.NeytsJ.DeClercqE.JonesK.HrubyD.JordanR.An orally bioavailable antipoxvirus compound"/>
 <result pre="of respiratory syncytial virus infection in the upper and lower" exact="respiratory" post="tractJ. Mol. Biol.368200765266517362988 YangG.PevearD.C.DaviesM.H.CollettM.S.BaileyT.RippenS.BaroneL.BurnsC.RhodesG.TohanS.HugginsJ.W.BakerR.O.BullerR.L.TouchetteE.WallerK.SchriewerJ.NeytsJ.DeClercqE.JonesK.HrubyD.JordanR.An orally bioavailable antipoxvirus compound (ST-246)"/>
 <result pre="protects mice from lethal orthopoxvirus ChallengeJ. Virol.792005131391314916189015 YarchoanR.BergG.BrouwersP.FischlM.A.SpitzerA.R.WichmanA.GrafmanJ.ThomasR.V.SafaiB.BrunettiA.Response of human-immunodeficiency-virus-associated" exact="neurological disease" post="to 3′-azido-3′-deoxythymidineLancet119871321352879972"/>
 <result pre="mice from lethal orthopoxvirus ChallengeJ. Virol.792005131391314916189015 YarchoanR.BergG.BrouwersP.FischlM.A.SpitzerA.R.WichmanA.GrafmanJ.ThomasR.V.SafaiB.BrunettiA.Response of human-immunodeficiency-virus-associated neurological" exact="disease" post="to 3′-azido-3′-deoxythymidineLancet119871321352879972"/>
</results>
